CYP2C19 pharmacogenetics in the clinical use of proton-pump inhibitors for gastro-oesophageal reflux disease: variant alleles predict gastric acid suppression, but not oesophageal acid exposure or reflux symptoms.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples